Login to Your Account

Elan Seeking US$1B In Asset Sale As Top Executive Departs

By Cormac Sheridan

Wednesday, July 10, 2002
DUBLIN, Ireland - The top slot at ailing Irish biopharmaceutical firm Elan Corp. plc became available Tuesday as Chairman and CEO Donal Geaney vacated both roles, following a share price meltdown last Thursday, when Standard & Poor's reduced the company's debt rating to junk bond status. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription